04, 2025 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
However, frequent stop-start cycles often lead to frustration and weight cycling, which is why most doctors recommend either continuous therapy or extended pauses with strong behavioral support
GLP-1, glucagon-like peptide-1
Wild concept, apparently
Some notable options include PlushCare, which offers personalized weight loss programs with virtual consultations, and Noom Med, which combines GLP-1 medications with behavioral coaching
They will not be the last, and they will likely not remain the most effective
